Submitted by dcc on Thu, 2018-05-10 09:30 Study Title: A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or Crizotinib Added to Standard Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL) (IND# 134379)CIRB: Pediatric CIRBLead Group: COGStatus: ActiveReview Status: Available to Open
